1. Home
  2. MRVI vs TCI Comparison

MRVI vs TCI Comparison

Compare MRVI & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.61

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Logo Transcontinental Realty Investors Inc.

TCI

Transcontinental Realty Investors Inc.

HOLD

Current Price

$53.00

Market Cap

380.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
TCI
Founded
2014
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
449.6M
380.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MRVI
TCI
Price
$3.61
$53.00
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.58
N/A
AVG Volume (30 Days)
1.5M
1.8K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
75.87
EPS
N/A
0.65
Revenue
$192,435,000.00
$48,675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
N/A
$76.80
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$25.50
52 Week High
$6.21
$51.71

Technical Indicators

Market Signals
Indicator
MRVI
TCI
Relative Strength Index (RSI) 54.00 76.55
Support Level $3.50 $43.01
Resistance Level $3.95 $45.00
Average True Range (ATR) 0.18 1.28
MACD -0.01 0.76
Stochastic Oscillator 46.46 100.00

Price Performance

Historical Comparison
MRVI
TCI

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

Share on Social Networks: